Evidence map›Paper›PMID 37261502›Full record

ArticleCellular and molecular life sciences : CMLS2023

Interleukin 1β triggers synaptic and memory deficits in Herpes simplex virus type-1-infected mice by downregulating the expression of synaptic plasticity-related genes via the epigenetic MeCP2/HDAC4 complex.

Domenica Donatella Li Puma, Claudia Colussi, Bruno Bandiera, Giulia Puliatti, Marco Rinaudo, Sara Cocco, Fabiola Paciello, Agnese Re, Cristian Ripoli, Giovanna De Chiara and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Domenica Donatella Li Puma *Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0001-6729-6967
Claudia Colussi *Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.ORCID http://orcid.org/0000-0002-7727-8911
Bruno BandieraDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0002-8311-7241
Giulia PuliattiDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0002-9275-4576
Marco RinaudoDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0002-6130-7335
Sara CoccoDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0002-9769-1519
Fabiola PacielloDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0002-8473-8074
Agnese ReDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0003-0929-6568
Cristian RipoliDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0002-5315-0163
Giovanna De ChiaraInstitute of Translational Pharmacology, National Research Council (CNR), 00133, Rome, Italy.ORCID http://orcid.org/0000-0002-2219-6097
Alessia BertozziDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0003-1025-5034
Anna Teresa PalamaraDepartment of Infectious Diseases, Istituto Superiore Di Sanità, 00161, Rome, Italy.ORCID http://orcid.org/0000-0001-8330-4381
Roberto PiacentiniDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy. roberto.piacentini@unicatt.it.ORCID http://orcid.org/0000-0003-4215-1643
Claudio GrassiDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.ORCID http://orcid.org/0000-0001-7253-1685
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · ITIstituto di Farmacologia Traslazionale · ITIstituto Superiore di Sanità · IT

Funding

Ministero della Salute Ricerca Corrente 2023 - Fondazione Policlinico Universitario A. Gemelli IRCCSMinistero dell'Istruzione, dell'Università e della Ricerca 20179JHAMZ_006Ministero dell'Istruzione, dell'Università e della Ricerca 2017A9MK4R_004Ministero dell'Istruzione, dell'Università e della Ricerca FOE2020:project title "Nuovi biomarker diagnostici e terapeutici delle malattie neurodegenerative"Università Cattolica del Sacro Cuore D1 intramural funds
6 · The paper itself

Abstract

Extensive research provides evidence that neuroinflammation underlies numerous brain disorders. However, the molecular mechanisms by which inflammatory mediators determine synaptic and cognitive dysfunction occurring in neurodegenerative diseases (e.g., Alzheimer's disease) are far from being fully understood. Here we investigated the role of interleukin 1β (IL-1β), and the molecular cascade downstream the activation of its receptor, to the synaptic dysfunction occurring in the mouse model of multiple Herpes simplex virus type-1 (HSV-1) reactivations within the brain. These mice are characterized by neuroinflammation and memory deficits associated with a progressive accumulation of neurodegenerative hallmarks (e.g., amyloid-β protein and tau hyperphosphorylation). Here we show that mice undergone two HSV-1 reactivations in the brain exhibited increased levels of IL-1β along with significant alterations of: (1) cognitive performances; (2) hippocampal long-term potentiation; (3) expression synaptic-related genes and pre- and post-synaptic proteins; (4) dendritic spine density and morphology. These effects correlated with activation of the epigenetic repressor MeCP2 that, in association with HDAC4, affected the expression of synaptic plasticity-related genes. Specifically, in response to HSV-1 infection, HDAC4 accumulated in the nucleus and promoted MeCP2 SUMOylation that is a post-translational modification critically affecting the repressive activity of MeCP2. The blockade of IL-1 receptors by the specific antagonist Anakinra prevented the MeCP2 increase and the consequent downregulation of gene expression along with rescuing structural and functional indices of neurodegeneration. Collectively, our findings provide novel mechanistic evidence on the role played by HSV-1-activated IL-1β signaling pathways in synaptic deficits leading to cognitive impairment.

Indexed as

Alzheimer DiseaseHerpes SimplexHerpesvirus 1, HumanAnimalsDisease Models, AnimalEpigenesis, GeneticHippocampusInterleukin-1betaMemory DisordersMethyl-CpG-Binding Protein 2MiceNeuroinflammatory DiseasesNeuronal PlasticityInterleukin-1betaMecp2 protein, mouseMethyl-CpG-Binding Protein 2AnakinraMemoryNeurodegenerationNeuroinflammationSUMOylationSynaptic function

Identifiers

PMID37261502
PMCPMC10234878
OpenAlexW4378952284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.